Let’s Talk! HIV Vaccines 101
Webinars • 2022On May 18, 2022, Treatment Action Group (TAG), the Black AIDS Institute (BAI), and the Southern AIDS Coalition (SAC) participated in this fun and informative Instagram Live discussion commemorating HIV Vaccine Awareness. Day.
World Malaria Day 2022 Long-Acting Technologies Community Advisory Board (LAT-CAB) Statement
Statement / Press • 2022As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing 12 countries, vast civil society networks, and people living with and affected by malaira, HIV, tuberculosis, and hepatitis C across the world – in reflection of World Malaria Day on April 25, 2022 – we are shocked and united in anger at the health disparities and slow progress in meeting malaria eradication goals set out in the WHO Global Technical Strategy for Malaria 2016-2030.
Launch of Public Health Partnership to Tackle the Silent Epidemic of Hepatitis C in Low- and Middle-Income Countries
Statement / Press • 2021The Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND, the global alliance for diagnostics, and the Treatment Action Group are joining forces to tackle a ‘silent’ public health injustice: the continuing disparities in access to diagnostics and treatment for the hepatitis C virus (HCV) in low- and middle-income countries (LMICs), home to 75% of those living with this viral illness.
Vacunas de VIH e Inmunización Pasiva
PDF • 2021Know Your CAB: Community Experts Shaping the Long-Acting Technologies Pipeline
TAGline • 2021By Bryn Gay, Joelle Dountio Ofimboudem, and Kenly Sikwese* Meaningful and equitable community engagement is essential to ensuring that long-acting technologies (LATs) clinical research is conducted in ways that are safe, ethical, appropriate, and responsive to community priorities and needs.1 To advance the community engagement work, Treatment Action Group (TAG) and the African Community Advisory…
Community Movements Across Africa, Asia and South America Celebrate Roll-Out of Short-Course, Patient-Friendly TB Preventive Therapy
Statement / Press • 2021Advocates and affected communities working towards the global scale-up of short-course TB preventive therapy (TPT) hail the recent announcement of the launch of decently priced, patient-friendly fixed-dose combinations (FDC) of 3HP in five high burden HIV and TB countries.
Letter to NYC Government Officials About Reported de Blasio Plan to Put Health + Hospitals in Contact Tracing Leadership Role
Letters PDF • 2020The COVID-19 Working Group New York sent this letter responding to reports that NYC Mayor Bill de Blasio is planning to put Health + Hospitals in the leadership role of a new initiative of COVID-19 contact tracing, a “reckless and potentially disastrous departure from sound public health practice.”
Répondre aux Sous-Types de VHC Difficiles à Traiter Répandus en Afrique Subsaharienne (French)
PDF • 2020Letter to Sanofi CEO Calling for Patent Withdrawals on Critical TB Drugs
Letters • 2020TAG and our French partners OTMeds (Observatoire de la transparence dans les politiques du médicaments) sent a letter to Sanofi CEO Paul Hudson calling on the company to reverse its efforts to patent two obvious combinations of two critical drugs to prevent tuberculosis: rifapentine and isoniazid.
Treatment Action Group Regrets NYC Health Commissioner Oxiris Barbot’s Resignation
Statement / Press • 2020Treatment Action Group, the New York City-based research, policy, and advocacy organization, deplores the August 4, 2020 departure of New York’s Department of Health Commissioner, Dr. Oxiris Barbot, MD.